Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis
机构:[1]Duke University School of Medicine, Durham, NC, USA[2]The Ottawa Hospital Research Institute, Ottawa, ON, Canada[3]University of Toronto, Toronto, Canada[4]Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada[5]Thomas Jeferson University, Philadelphia, USA[6]University of Ottawa, Ottawa, Canada[7]McMaster University, Hamilton, Canada[8]Jewish General Hospital, Montreal, Canada[9]University of Montreal, Montreal, Canada[10]Taibah University, Medina, Saudi Arabia[11]The University of Texas Southwestern Medical Center, Dallas, USA[12]Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA[13]Medical University of Warsaw, Warsaw, Poland[14]University of Pittsburgh, Pittsburgh, USA[15]Section of Radiology - Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, Palermo, Italy[16]Université Paris Cité, Paris, France[17]University of Ulsan, Ulsan, Republic of Korea[18]Nottingham University Hospitals NHS Trust, Nottingham, UK[19]Tianjin Third Central Hospital, Tianjin, China[20]Weill Cornell Medical Center, New York, NY, USA[21]West China Hospital of Sichuan University, Chengdu, China四川大学华西医院[22]Jeonbuk National University Medical School and Hospital, Jeonju, Republic of Korea[23]University Hospital of Zurich, Zurich, Switzerland[24]Seoul National University Hospital, Seoul, Republic of Korea[25]Dong-A University Hospital, Busan, Republic of Korea[26]Zhongshan Hospital, Fudan University, Shanghai, China[27]Images and Diagnosis Department, Universidad Austral, Buenos Aires, Argentina[28]Hepatology and Liver Transplant Unit, Universidad Austral, Buenos Aires, Argentina[29]Yonsei University Health System, Seoul, Republic of Korea[30]Sun Yat-sen University, Guangzhou, China[31]Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea[32]Queen Elizabeth II Health Sciences Centre, Halifax, Canada
第一作者机构:[1]Duke University School of Medicine, Durham, NC, USA
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Nicole Abedrabbo,Emily Lerner,Eric Lam,et al.Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis[J].Abdominal Radiology (New York).2024,doi:10.1007/s00261-024-04580-6.
APA:
Nicole Abedrabbo,Emily Lerner,Eric Lam,Diana Kadi,Haben Dawit...&Mustafa Bashir.(2024).Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis.Abdominal Radiology (New York),,
MLA:
Nicole Abedrabbo,et al."Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis".Abdominal Radiology (New York) .(2024)